AMLODIPINE BESYLATE AND CELECOXIB (Consensi) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

AMLODIPINE BESYLATE AND CELECOXIB

What is the Trade Name for AMLODIPINE BESYLATE AND CELECOXIB

Consensi

What is the Indication for AMLODIPINE BESYLATE AND CELECOXIB

  • 1 INDICATIONS AND USAGE CONSENSI is a combination of amlodipine besylate, a calcium channel blocker, and celecoxib, a nonsteroidal anti-inflammatory drug (NSAID), indicated for patients for whom treatment with amlodipine for hypertension and celecoxib for osteoarthritis are appropriate. Lowering blood pressure reduces the risk of fatal and nonfatal CV events, primarily strokes and myocardial infarctions. ( 1.1 ) Limitations of Use CONSENSI is only available in a celecoxib strength of 200 mg and is only to be taken once daily. ( 1.1 ) 1.1 Hypertension and Osteoarthritis CONSENSI is indicated in adult patients for whom treatment with both amlodipine for hypertension and celecoxib for osteoarthritis are appropriate. Amlodipine Amlodipine is indicated for the treatment of hypertension, to lower blood pressure [see Clinical Studies (14.1) ] . Lowering blood pressure reduces the risk of fatal and nonfatal CV events, primarily strokes and myocardial infarctions. Amlodipine may be used alone or in combination with other antihypertensive agents [see Drug Interactions (7) ]. Celecoxib Celecoxib is indicated for the management of the signs and symptoms of osteoarthritis [see Clinical Studies (14.2) ]. Limitations of Use CONSENSI is inappropriate for short-term or intermittent treatment or to treat any conditions other than hypertension in patients taking celecoxib for osteoarthritis. CONSENSI is only available in a celecoxib strength of 200 mg and is only to be taken once daily.

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]